George Wilmot
Neurology · Atlanta, GANPI 1174531313
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Biohaven Pharmaceutical Holding Company Ltd. accounts for 79.3% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for neurology clinicians in GA, where the typical reported total is $1,471.
Across 4 payments — averaging $47.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$152
- GE HealthCare$40
Across 19 payments — averaging $4901.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biohaven Pharmaceuticals, Inc.$57K
- Biogen$18K
- Biohaven Pharmaceutical Holding Company Ltd.$18K
What the payments were for
- Food & beverage$192100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $152 |
| GE HealthCare | 2 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$119
How this compares
$192 in reported general payments places this provider in the 25th percentile of 506 neurology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SkyclarysOmaveloxolone | 23 | $718,945 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 51 | $439,451 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 18 | $316,903 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 16 | $113,910 |
| Mycophenolate Mofetil | 12 | $3,996 |
| Bupropion XlBupropion Hcl | 16 | $1,218 |
| Baclofen | 30 | $1,024 |
| Gabapentin | 24 | $1,010 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 14 | $861 |
| Diazepam | 48 | $778 |
| Sodium Chloride0.9 % Sodium Chloride | 17 | $362 |
| Escitalopram Oxalate | 12 | $178 |
| Pregabalin | 16 | $177 |
Paid to pharmacies, not to this prescriber.
Other neurology in Atlanta
- Joash LazarusAtlanta$1.1M
- Jeffrey EnglishAtlanta$749K
- Frank BerensonAtlanta$527K
- Julio FlaminiAtlanta$501K
- Douglas StuartAtlanta$493K
- Robert GilbertAtlanta$412K
- Lawrence SeidenAtlanta$272K
- Jacqueline RosenthalAtlanta$241K
- Ben ThrowerAtlanta$203K
- Jaime Hatcher MartinAtlanta$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.